Cargando…
Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital
INTRODUCTION: Cancer patients are more vulnerable to coronavirus disease 2019 (COVID-19) owing to their compromised immune status. However, data regarding COVID-19 vaccine safety and immune response in cancer patients are scarce. METHOD: This prospective, age- and sex-matched, single-center cohort s...
Autores principales: | Limpawittayakul, Piyarat, Sungkasubun, Prakongboon, Chaiwiriyawong, Worawit, Supavavej, Archara, Weerasubpong, Bowon, Siripaibun, Jomtana, Phanthunane, Chumut, Lamlertthon, Wisut, Ungtrakul, Teerapat, Tawinprai, Kriangkrai, Tantiyavarong, Walaipan, Samdaengpan, Chayanee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746434/ https://www.ncbi.nlm.nih.gov/pubmed/35976687 http://dx.doi.org/10.1080/21645515.2022.2104058 |
Ejemplares similares
-
Difference in Immunogenic Responses to COVID-19 Vaccines in Patients With Cancer Receiving Chemotherapy Versus Nonchemotherapy Treatment
por: Tantiyavarong, Walaipan, et al.
Publicado: (2023) -
Papillary Renal Cell Carcinoma Presented With Supraclavicular Lymph Node Metastasis Without Renal Primary Lesion
por: Thamcharoen, Natanong, et al.
Publicado: (2013) -
“A Good Personal Scientific Relationship”: Philip Morris Scientists and the Chulabhorn Research Institute, Bangkok
por: MacKenzie, Ross, et al.
Publicado: (2008) -
Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
por: Cohen, Guy, et al.
Publicado: (2022) -
Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing
por: Intarajak, Thoranin, et al.
Publicado: (2019)